Experimental Investigation of Compact Evaporators for Ultra Low Temperature Refrigeration of Microprocessors

It is well known that microprocessor performance can be improved by lowering the junction temperature. Two stage cascaded vapor compression refrigeration (VCR) is a mature, inexpensive, and reliable cooling technology that can offer chip temperatures down to ?? C. Recent studies have shown that for a power limited computer chip, there is a non-linear scaling effect that offers a 4.3X performance enhancement at ?? C. The heat transfer performance of a compact evaporator is often the bottleneck in sub-ambient heat removal. For this reason, the design of a deep sub-ambient compact evaporator is critical to the cooling system performance and has not been addressed in the literature. Four compact evaporator designs were investigated as feasible designs - a baseline case with no enhancement structures, micro channels, inline pin fin arrays, and alternating pin fin arrays. A parametric experimental investigation of four compact evaporator designs has been performed aiming at enhancing heat transfer. Each evaporator consists of oxygen free copper and has a footprint of 20 mm x 36 mm, with a total thickness of 3.1 mm. The micro channel evaporator contains 13 channels that are 400 um wide by 1.2 mm deep, and the pin fin evaporators contain approximately 80 pin fins that are 400 um wide by 1.2 mm tall with a pitch of 800 um. Two phase convective boiling of R508b refrigerant was investigated in each evaporator at flow rates of 50 - 70 g/min and saturation temperatures of ??to ??C. Pressure drop and local heat transfer measurements are reported and used to explain the performance of the various evaporator geometries. The results are compared to predictions from popular macro- and micro-channel heat transfer and pressure drop correlations. The challenges of implementing a two stage cascade VCR systems for microprocessor refrigeration are also discussed.M.S.Committee Chair: Yogendra Joshi; Committee Co-Chair: Andrei Fedorov; Committee Member: Paul Koh

A Novel and Rapid PCR-Based Method for Genotyping Human Papillomaviruses in Clinical Samples

Many human papillomavirus (HPV) genotypes are associated with cervical carcinoma. We demonstrate the utility of an innovative technique for genotyping of HPV in cervical tissue samples. This method provides an accurate means of identification of the specific HPV genotypes present in clinical specimens. By using the MY09-MY11 and the GP5(+)-GP6(+) consensus primer pairs, HPV sequences were amplified by nested PCR from DNA isolated from cervical smear samples. This led to the production of an approximately 140-bp PCR product from the L1 (major capsid) gene of any of the HPVs present in the sample. PCR was performed with a deoxynucleoside triphosphate mixture which resulted in the incorporation of deoxyuridine into the amplified DNA product at positions where deoxythymidine would normally be incorporated at a frequency of about once or twice per strand. Following the PCR, the product was treated with an enzyme mix that contains uracil N-glycosylase (UNG) and endonuclease IV. UNG removes the uracil base from the nucleotide, and endonuclease IV cleaves the phosphodiester bond at this newly formed abasic site, producing fragments of various sizes. By having end labeled one of the amplification primers, a DNA ladder which is analogous to a “T-sequencing ladder” was produced upon electrophoresis of the products. By comparing this T-sequencing ladder to the known sequences of HPVs, the genotypes of unknown HPV isolates in samples were assigned. Data showing the utility of this technique for the rapid analysis of clinical samples are presented

Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers

To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldThe Nordic countries have a long tradition of large-scale biobanking and comprehensive, population-based health data registries linkable on unique personal identifiers, enabling follow-up studies spanning many decades. Joint Nordic biobank-based studies provide unique opportunities for longitudinal molecular epidemiological research. The purpose of the present paper is to describe the possibilities for such joint studies, by describing some of the major Nordic biobank cohorts with a standardised calculation of the cancer incidence in these cohorts. Altogether two million donors have since 1966 donated more than four million biological samples, stored at -20 degrees C to -135 degrees C, to 17 biobank cohorts in Finland, Iceland, Norway and Sweden. As a result of joint database handling principles, the accuracy of personal identifiers and completeness of follow-up for vital status in all participating biobanks was improved. Thereafter, the cancer incidence was determined using follow-up through the national cancer registries. Biobanks based on random samples of population typically showed slightly lower cancer incidence rates than the general population, presumably due to better participation rates among health-conscious subjects. On the other hand, biobanks including samples for viral screening or clinical testing showed 1.5 to 2.1 fold increased incidence of cancer. This excess was very high immediately after sampling, but for some cancer sites remained elevated for years after clinical sampling. So far, more than 100 000 malignant neoplasms have occurred after sample donation, and the annual increase of the cancer cases in these cohorts is about 10 000. The estimates on the population-representativity of the biobanks will assist in interpretation of generalizability of results of future studies based on these samples, and the systematic tabulations of numbers of cancer cases will serve in study power estimations. The present paper summarizes optimal study designs of biobank-based studies of cancer